Disclosing the potential impact of placebo controls in antidepressant trials

Disclosing the potential impact of placebo controls in antidepressant trials

Background Although placebo-control clinical trials that withhold effective treatments can be permissible, how best to inform participants of the placebo design has received little attention. Aims To...

Full description

Bibliographic Details
Main Authors:	Stephanie C. Chen, Cheryl McCullumsmith, Scott Y. H. Kim
Format:	Article
Language:	English
Published:	Cambridge University Press 2015-06-01
Series:	BJPsych Open
Online Access:	https://www.cambridge.org/core/product/identifier/S2056472400000752/type/journal_article

Similar Items

Dr. Lance Dworkin: A Pioneer in Medicine and Research
by: Robert McCullumsmith
Published: (2023-12-01)

Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.
by: Ludovic Trinquart, et al.
Published: (2012-01-01)

HOW IMPORTANT IS PLACEBO IN ANTIDEPRESSANT TRIALS?
by: Cipriani, A
Published: (2010)

Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis
by: Salanti, G, et al.
Published: (2018)

Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.
by: Ogawa, Y, et al.
Published: (2017)

Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
by: Lisa Holper, et al.
Published: (2020-09-01)

Randomized controlled trial: Quantifying the impact of disclosing uncertainty on adherence to hypothetical health recommendations.
by: Hannah Mendoza, et al.
Published: (2022-01-01)

Neural Predictors of the Antidepressant Placebo Response
by: Danielle Rette, et al.
Published: (2019-10-01)

Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
by: Barnes, T, et al.
Published: (2016)

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
by: Thomas RE Barnes, et al.
Published: (2016-04-01)

SSRIs: Applications in inflammatory lung disease and implications for COVID‐19
by: Claire Kyung Sun Meikle, et al.
Published: (2021-09-01)

Individual differences in response to antidepressants: a meta-analysis of placebo-controlled randomized clinical trials
by: Maslej, MM, et al.
Published: (2021)

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies
by: Furukawa, T, et al.
Published: (2016)

Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy.
by: Furukawa, T, et al.
Published: (2018)

HIV/AIDS, TO DISCLOSE OR NOT TO DISCLOSE: THAT IS THE QUESTION
by: Andra le Roux-Kemp
Published: (2013-04-01)

Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
by: Ali S. Imami, et al.
Published: (2021-11-01)

Using protein turnover to expand the applications of transcriptomics
by: Marissa A. Smail, et al.
Published: (2021-02-01)

Antidepressants versus placebo for panic disorder in adults
by: Bighelli, I, et al.
Published: (2018)

Polygenic heterogeneity in antidepressant treatment and placebo response
by: Anne Krogh Nøhr, et al.
Published: (2022-10-01)

Challenging Received Wisdom: Antidepressants and the Placebo Effect
by: Irving Kirsch
Published: (2020-12-01)

The duty to disclose adverse clinical trial results.
by: Liao, S, et al.
Published: (2009)

Neuroimaging Studies of Antidepressant Placebo Effects: Challenges and Opportunities
by: Vanessa Brown, et al.
Published: (2019-09-01)

Randomization should be disclosed to potential research subjects.
by: Binik, A, et al.
Published: (2013)

Controlling and disclosing your personal information
by: Mohamed Sidek, Zailani, et al.
Published: (2009)

AMPA receptor subunit expression in the endoplasmic reticulum in frontal cortex of elderly patients with schizophrenia.
by: John C Hammond, et al.
Published: (2012-01-01)

Disclosing Interstices
by: Sitong Luo
Published: (2021-09-01)

Disclosing clinical trial results: publicity, significance and independence.
by: Liao, S, et al.
Published: (2009)

PAVER: Pathway Analysis Visualization with Embedding Representations
by: William Ryan, et al.
Published: (2023-12-01)

Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial
by: Kathryn R. Hill, et al.
Published: (2021-01-01)

Brexpiprazole versus placebo or other antidepressive agents for treating depression
by: Ralovska, S, et al.
Published: (2021)

Significance of Participants’ Expectations in Managing the Placebo Effect in Antidepressant Research
by: Marko Curkovic, et al.
Published: (2019-10-01)

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease
by: A Schrag, et al.
Published: (2022-12-01)

Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia
by: Smita Sahay, et al.
Published: (2023-12-01)

Need to disclose disability
by: Mohd Noor, Alisha Nur
Published: (2019)

Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data
by: Shinohara, K, et al.
Published: (2019)

Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?
by: Leucht, S, et al.
Published: (2018)

Decreased chloride channel expression in the dorsolateral prefrontal cortex in schizophrenia.
by: Courtney R Sullivan, et al.
Published: (2015-01-01)

Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials
by: Noma, H, et al.
Published: (2019)

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
by: S Banerjee, et al.
Published: (2013-02-01)

The impact of disclosing emotions on ratings of interpersonal closeness, warmth, competence, and leadership ability
by: Vera U. Ludwig, et al.
Published: (2022-12-01)